Laminin-5, Fibronectin, and Type IV Collagen as Potential Biomarkers of Brain Glioma Malignancy
The presented work is based on the quantification of LN-5, FN, and COL IV in blood plasma as potential biomarkers in patients diagnosed with glioma in grades G1 to G4. The obtained concentration results were compared with the protein content in the control group, which consisted of smokers of differ...
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-09-01
|
Series: | Biomedicines |
Subjects: | |
Online Access: | https://www.mdpi.com/2227-9059/10/9/2290 |
_version_ | 1827663174712688640 |
---|---|
author | Lukasz Oldak Sylwia Chludzinska-Kasperuk Patrycja Milewska Kamil Grubczak Joanna Reszec Ewa Gorodkiewicz |
author_facet | Lukasz Oldak Sylwia Chludzinska-Kasperuk Patrycja Milewska Kamil Grubczak Joanna Reszec Ewa Gorodkiewicz |
author_sort | Lukasz Oldak |
collection | DOAJ |
description | The presented work is based on the quantification of LN-5, FN, and COL IV in blood plasma as potential biomarkers in patients diagnosed with glioma in grades G1 to G4. The obtained concentration results were compared with the protein content in the control group, which consisted of smokers of different ages. The obtained results were statistically analysed and interpreted based on the available clinical description. Quantitative determinations of LN-5, FN, and COL IV were performed with the use of SPRi biosensors specific to the tested proteins. Comparing groups K and G4, as well as G2 and G4, statistically significant relationships between changes in the concentration of individual proteins, were observed. The analysis showed significant correlations between FN and LN-5, between FN and COL IV, and between LN-5 and COL IV. There was a moderate positive correlation between individual proteins and the age of the patient. The ROC analysis distinguished patients with advanced disease from the control group. The results of the research show that LN-5, FN, and COL IV are effective biomarkers of brain glioma that may be helpful in non-invasive diagnosis and determining the grade of the disease. |
first_indexed | 2024-03-10T00:38:13Z |
format | Article |
id | doaj.art-41de85385d06401284052899be6a95e0 |
institution | Directory Open Access Journal |
issn | 2227-9059 |
language | English |
last_indexed | 2024-03-10T00:38:13Z |
publishDate | 2022-09-01 |
publisher | MDPI AG |
record_format | Article |
series | Biomedicines |
spelling | doaj.art-41de85385d06401284052899be6a95e02023-11-23T15:12:19ZengMDPI AGBiomedicines2227-90592022-09-01109229010.3390/biomedicines10092290Laminin-5, Fibronectin, and Type IV Collagen as Potential Biomarkers of Brain Glioma MalignancyLukasz Oldak0Sylwia Chludzinska-Kasperuk1Patrycja Milewska2Kamil Grubczak3Joanna Reszec4Ewa Gorodkiewicz5Bioanalysis Laboratory, Faculty of Chemistry, University of Bialystok, Ciolkowskiego 1K, 15-245 Bialystok, PolandBiobank, Medical University of Bialystok, Waszyngtona 13, 15-269 Bialystok, PolandBiobank, Medical University of Bialystok, Waszyngtona 13, 15-269 Bialystok, PolandDepartment of Regenerative Medicine and Immune Regulation, Medical University of Bialystok, Waszyngtona 13, 15-269 Bialystok, PolandBiobank, Medical University of Bialystok, Waszyngtona 13, 15-269 Bialystok, PolandBioanalysis Laboratory, Faculty of Chemistry, University of Bialystok, Ciolkowskiego 1K, 15-245 Bialystok, PolandThe presented work is based on the quantification of LN-5, FN, and COL IV in blood plasma as potential biomarkers in patients diagnosed with glioma in grades G1 to G4. The obtained concentration results were compared with the protein content in the control group, which consisted of smokers of different ages. The obtained results were statistically analysed and interpreted based on the available clinical description. Quantitative determinations of LN-5, FN, and COL IV were performed with the use of SPRi biosensors specific to the tested proteins. Comparing groups K and G4, as well as G2 and G4, statistically significant relationships between changes in the concentration of individual proteins, were observed. The analysis showed significant correlations between FN and LN-5, between FN and COL IV, and between LN-5 and COL IV. There was a moderate positive correlation between individual proteins and the age of the patient. The ROC analysis distinguished patients with advanced disease from the control group. The results of the research show that LN-5, FN, and COL IV are effective biomarkers of brain glioma that may be helpful in non-invasive diagnosis and determining the grade of the disease.https://www.mdpi.com/2227-9059/10/9/2290gliomalaminin-5fibronectintype IV collagenSPRi biosensorsbasement membrane in carcinoma |
spellingShingle | Lukasz Oldak Sylwia Chludzinska-Kasperuk Patrycja Milewska Kamil Grubczak Joanna Reszec Ewa Gorodkiewicz Laminin-5, Fibronectin, and Type IV Collagen as Potential Biomarkers of Brain Glioma Malignancy Biomedicines glioma laminin-5 fibronectin type IV collagen SPRi biosensors basement membrane in carcinoma |
title | Laminin-5, Fibronectin, and Type IV Collagen as Potential Biomarkers of Brain Glioma Malignancy |
title_full | Laminin-5, Fibronectin, and Type IV Collagen as Potential Biomarkers of Brain Glioma Malignancy |
title_fullStr | Laminin-5, Fibronectin, and Type IV Collagen as Potential Biomarkers of Brain Glioma Malignancy |
title_full_unstemmed | Laminin-5, Fibronectin, and Type IV Collagen as Potential Biomarkers of Brain Glioma Malignancy |
title_short | Laminin-5, Fibronectin, and Type IV Collagen as Potential Biomarkers of Brain Glioma Malignancy |
title_sort | laminin 5 fibronectin and type iv collagen as potential biomarkers of brain glioma malignancy |
topic | glioma laminin-5 fibronectin type IV collagen SPRi biosensors basement membrane in carcinoma |
url | https://www.mdpi.com/2227-9059/10/9/2290 |
work_keys_str_mv | AT lukaszoldak laminin5fibronectinandtypeivcollagenaspotentialbiomarkersofbraingliomamalignancy AT sylwiachludzinskakasperuk laminin5fibronectinandtypeivcollagenaspotentialbiomarkersofbraingliomamalignancy AT patrycjamilewska laminin5fibronectinandtypeivcollagenaspotentialbiomarkersofbraingliomamalignancy AT kamilgrubczak laminin5fibronectinandtypeivcollagenaspotentialbiomarkersofbraingliomamalignancy AT joannareszec laminin5fibronectinandtypeivcollagenaspotentialbiomarkersofbraingliomamalignancy AT ewagorodkiewicz laminin5fibronectinandtypeivcollagenaspotentialbiomarkersofbraingliomamalignancy |